Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AMCP 2026 13 - 16 April 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiology
Congress poster
RNAi
Pipeline
RWE